Since the PI3K/AKT/mTOR pathway is aberrantly active in DLBCL and plays a role in the genesis and progression of DLBCL [365–369], researchers have also investigated its role in PCNSL. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.